2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one
C36H36N2O3 — CID 139672501
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one
2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one (PubChem CID 139672501) has the molecular formula C36H36N2O3 and a molecular weight of 544.70 g/mol. Its IUPAC name is 2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one.
Molecular Properties
| Compound Name | 2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one |
|---|---|
| PubChem CID | 139672501 |
| Molecular Formula | C36H36N2O3 |
| Molecular Weight | 544.70 g/mol |
| Exact Mass | 544.27 |
| IUPAC Name | 2'-anilino-6'-(3,3-diethyl-2-methylpyrrolidin-1-yl)-3'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one |
| SMILES | CCC1(CC)CCN(c2ccc3c(c2)Oc2cc(C)c(Nc4ccccc4)cc2C32OC(=O)c3ccccc32)C1C |
| InChI | InChI=1S/C36H36N2O3/c1-5-35(6-2)18-19-38(24(35)4)26-16-17-29-33(21-26)40-32-20-23(3)31(37-25-12-8-7-9-13-25)22-30(32)36(29)28-15-11-10-14-27(28)34(39)41-36/h7-17,20-22,24,37H,5-6,18-19H2,1-4H3 |
| InChIKey | FPDMTMFQJJBIBZ-UHFFFAOYSA-N |
| XLogP | 8.71 |
| TPSA | 50.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 544.70 |
| LogP ≤ 5 | 8.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139672501 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.